pazopanib (GW786034) 400 mg
VEG20007
Phase 2 small_molecule completed
Quick answer
pazopanib (GW786034) 400 mg for Neoplasms, Breast is a Phase 2 program (small_molecule) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline
- Indication
- Neoplasms, Breast
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed